Clinical Trial Update: Evaluation of Raltegravir During the Third Trimester of Pregnancy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating raltegravir during the third trimester of pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (Isentress) (raltegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection, PREGNANCY | Phase 2 | Status: COMPLETED